Mycobacterium tuberculosis Beijing Lineage and Risk for Tuberculosis in Child Household Contacts, Peru

Huang, Chuan-Chin; Chu, Alexander L.; Becerra, Mercedes C.; Galea, Jerome T; Calderón, Róger; Contreras, Carmen; Yataco, Rosa; Zhang, Zibiao; Lecca, Leonid; Murray, Megan

doi:10.3201/eid2603.191314

Cited by 16 publications

(20 citation statements)

References 44 publications

Supporting

Mentioning

Contrasting

Unclassified

Order By: Relevance

“…In line with previous studies and also in our study, Beijing strains were more common among BCG‐vaccinated TB patients in comparison to non‐immunized patients [18,21,29]. Despite this, there was a statistically significant relationship between Beijing‐ Mtb and drug resistance among people who had a history of BCG vaccination.…”

Section: Discussionsupporting

confidence: 92%

“…The genealogy of BCG strains displays a series of genomic alterations; including regions of deletion, this region included T cell epitopes that are essential to the human immune system response but had been lost in BCG strains to varying degrees [20]. Some studies have shown that BCG vaccination protects less efficiently against infection by Beijing strains compared with other genotypes [18,21]; conversely, there is a hypothesis that exposure to BCG‐induced immunity may select vaccine‐escape microorganism variants with a higher capacity for disease breakdown (vaccine‐escape specification) [22].…”

Section: Discussionmentioning

confidence: 99%

See 1 more Smart Citation

Does the BCG vaccine have different effects on strains of tuberculosis?

Kazemi

Farajnia

Ansarin

et al. 2020

Clinical and Experimental Immunology

View full text Add to dashboard Cite

Summary Several explanations have been suggested concerning the variety in bacille Calmette–Guerin (BCG) vaccine efficacy on strains of Mycobacterium tuberculosis (Mtb). This study aimed to compare the effect of BCG vaccination history in the prevention of the occurrence of Mtb-Beijing and non-Beijing strains. In this cross-sectional study, 64 patients with pulmonary tuberculosis (TB) were recruited from the Iranian border provinces (North West and West). Isolates were subjected to restriction fragment length polymorphism (RFLP) analysis, using the insertion sequence IS6110 as a probe (IS6110 RFLP) and drug susceptibility testing using the proportion method. Samples were analyzed with Gel Compare II 6.6 and spss version 18. The mean age [standard deviation (SD)] of the patients was 54·4 (SD = 17·0). Overall, 49 cases (76·56%) had no BCG vaccination scar. The prevalence of Beijing strains was 9·38% and drug resistance proportion among the isolates was 14·1% (nine cases). There was a significant relationship between Beijing strains and tuberculosis (TB)-drug resistance in isolates (χ2 = 26·29, P < 0·001). There was also a strong association between vaccination history and Beijing strains (χ2 = 13·23, P = 0·002). Also, a statistical relationship was observed between Beijing strains and drug-resistant TB among patients with a history of vaccination (χ2 = 7·47, P = 0·002). This association was not maintained in the unvaccinated group (P = 0·102). These findings confirm the claim that the vaccine has different effects on different subspecies of tuberculosis. The cause of the high probability of drug resistance in patients with Beijing-TB and vaccination history requires further investigation with a higher sample size.

show abstract

Section: Discussionsupporting

confidence: 92%

Section: Discussionmentioning

confidence: 99%

Does the BCG vaccine have different effects on strains of tuberculosis?

Kazemi

Farajnia

Ansarin

et al. 2020

Clinical and Experimental Immunology

View full text Add to dashboard Cite

show abstract

“…It is clear that immune responses differed when leukocytes were challenged with different lineages of Mtb . Such differences might explain the variability in vaccine efficacy among lineages of M. tuberculosis ( Chae & Shin, 2018 ; Huang et al., 2020 ). Further comparisons among lineages, such as using intracellular proteomic analysis and animal-infection models, might clarify this situation.…”

Section: Discussionmentioning

confidence: 99%

Characterisation of secretome-based immune responses of human leukocytes infected with variousMycobacterium tuberculosislineages

Kaewseekhao

Roytrakul

Yingchutrakul

et al. 2021

PeerJ

View full text Add to dashboard Cite

Background Differences in immune responses against different lineages of Mycobacterium tuberculosis (Mtb), and by different types of immune cell, are still poorly understood. We aimed to compare the secretome-based immune responses among three Mtb lineages and among immune-cell types. The immune responses were also investigated during infection and when the bacilli had been eliminated from the immune cells. Methods Human primary leukocytes were infected with strains representing three lineages of Mtb (East-Asian, Indo-Oceanic and Euro-American). Label-free GeLC MS/MS proteomic analysis of secretomes was performed. The response of each immune-cell type was compared with the appropriate interactome database for each. Results The expression pattern of proteins secreted by Mtb-infected leukocytes differed among Mtb lineages. The ancestral lineage (IO lineage) had a greater ability to activate MMP14 (associated with leukocyte migration) than did the more recent lineages (EA and EuA). During infection, proteins secreted by macrophages, dendritic cells, neutrophils and B-cells were associated with cell proliferation. Following clearance of Mtb, proteins associated with interferon signaling were found in macrophages, dendritic cells and neutrophils: proteins associated with antigen processing were found in B-cells and regulatory T-cells. Expression of immune response-related proteins from many immune-cell types might be suppressed by Mtb infection. Our study has provided a better insight into the host-pathogen interaction and immune response against different Mtb lineages.

show abstract

“…The sublineages with the lowest prevalence in Peru are X (3.1%), T (7.4%), S (0.32%), U (0.32%), MANU (0.01%), Ghana (0.01%), and EAI (0.01%); the presence of these sublineages correlates with the movement of people from the Asian region (Table 1). The percentage of unidentified strains (12.2%) is relatively low due to the implementation of molecular techniques such as spoligotyping, MIRU-VNTR (24 and 12 loci), and WGS to determine the transmission routes of TB (Barletta et al, 2013(Barletta et al, , 2015Cáceres et al, 2014;Cohen et al, 2011;Farhat et al, 2019;Grandjean et al, 2015Grandjean et al, , 2017Huang et al, 2020;Sheen et al, 2013;Taype et al, 2012).…”

Section: Perumentioning

confidence: 99%

“…Prevalence of the Beijing sublineage in Peru is the highest in South America (10.3%) due to population migration from China associated with labor, commercial and economic factors. China is one of the hotspots with the highest level of TB prevalence in the world (Grandjean et al, 2017;Huang et al, 2020;PAHO, 2020). XDR-TB reports also have a www.anatomiadigital.org higher incidence in this nation than in South America as a whole.…”

Section: Brazil and Peru Are Hotspots For Tuberculosis In South Americamentioning

confidence: 99%

Distribution of Mycobacterium tuberculosis lineages in South America

Vinueza

Paola

2021

View full text Add to dashboard Cite

Molecular genotyping of Mycobacterium tuberculosis allows for the identification of circulating lineages and sublineages in the population and their relationship with migratory movements. The purpose of this review is to describe the phylogeography of Mycobacterium tuberculosis reported in South American countries that was analyzed using genotyping tools, analyze the Tuberculosis hotspots for the region and determine the impact of the COVID-19 pandemic on the Tuberculosis control program. The Latin American Mediterranean (LAM) sublineage belonging to the Euro-American lineage (Lineage 4) presents the highest prevalence in South America and is followed by the Beijing sublineage belonging to the East Asian lineage (Lineage 2). The Beijing sublineage is considered of worldwide interest because of its association with multidrug-resistant tuberculosis (MDR-TB), which is almost entirely distributed in South America, with Peru being the country with the highest prevalence for this sublineage. On the other hand, the Indo-Oceanic (Lineage 1), India-East Asia (Lineage 3) and West- African 2 (Lineage 6) sublineages have been reported with lower prevalence in South America. The molecular techniques used in the genotyping studies for Mycobacterium tuberculosis in South America were as follows: typing by complementary oligonucleotide spacer sequences (Spoligotyping), restriction-hybridization patterns (IS6110-RFLP, PGRS-RFLP), mycobacterial interspaced repeat units-variable number tandem repeats (MIRU-VNTR) and whole genome sequencing (WGS). At present, Brazil and Peru are the hotspots for tuberculosis and MDR-TB in South America, where the control of tuberculosis wholly affected by the COVID-19 pandemic. Thus, there have been significant impacts on containment programs and possible post-pandemic scenarios such that scientific contributions will need to be evaluated and implemented with new strategies for prevention, diagnosis, treatment and control of Tuberculosis.

show abstract

Mycobacterium tuberculosis Beijing Lineage and Risk for Tuberculosis in Child Household Contacts, Peru

Cited by 16 publications

References 44 publications

Does the BCG vaccine have different effects on strains of tuberculosis?

Does the BCG vaccine have different effects on strains of tuberculosis?

Characterisation of secretome-based immune responses of human leukocytes infected with variousMycobacterium tuberculosislineages

Distribution of Mycobacterium tuberculosis lineages in South America

Contact Info

Product

Resources

About